Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

25 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma.
Tomsová M, Melichar B, Sedláková I, Steiner I. Tomsová M, et al. Among authors: sedlakova i. Gynecol Oncol. 2008 Feb;108(2):415-20. doi: 10.1016/j.ygyno.2007.10.016. Epub 2007 Nov 26. Gynecol Oncol. 2008. PMID: 18037158
[Lysophosphatidic acid in ovarian cancer patients].
Sedlákova I, Vávrová J, Tosner J, Hanousek L. Sedlákova I, et al. Ceska Gynekol. 2006 Jul;71(4):312-7. Ceska Gynekol. 2006. PMID: 16956044 Czech.
[Proteins of resistance and drug resistance in ovarian carcinoma patients].
Sedláková I, Laco J, Tošner J, Caltová K, Cervinka M, Rezáč A, Spaček J, Skapinec P. Sedláková I, et al. Klin Onkol. 2012;25(6):457-63. Klin Onkol. 2012. PMID: 23301649 Czech.
[Primary drug resistance/sensitivity in vitro and clininical outcome in ovarian cancer patients].
Sedláková I, Tosner J, Cervinka M, Brigulová K, Rezác A, Spacek J, Laco J, Skapinec P. Sedláková I, et al. Ceska Gynekol. 2011 Jun;76(3):184-9. Ceska Gynekol. 2011. PMID: 21838147 Czech.
Chemoresistance testing of human ovarian cancer cells and its in vitro model.
Brigulová K, Cervinka M, Tošner J, Sedláková I. Brigulová K, et al. Among authors: sedlakova i. Toxicol In Vitro. 2010 Dec;24(8):2108-15. doi: 10.1016/j.tiv.2010.08.010. Epub 2010 Aug 22. Toxicol In Vitro. 2010. PMID: 20736059
[Resistance/sensitivity in vitro in ovarian cancer patients].
Sedláková I, Tosner J, Rezác A, Cervinka M, Brigulová K, Spacek J, Tomsová M, Skapinec P. Sedláková I, et al. Ceska Gynekol. 2010 May;75(3):182-7. Ceska Gynekol. 2010. PMID: 20731297 Czech.
Lysophosphatidic acid: an ovarian cancer marker.
Sedláková I, Vávrová J, Tosner J, Hanousek L. Sedláková I, et al. Eur J Gynaecol Oncol. 2008;29(5):511-4. Eur J Gynaecol Oncol. 2008. PMID: 19051824
[Prognostic markers in ovarian carcinoma--retrospective study].
Tomsová M, Melichar B, Sedláková I, Nová M. Tomsová M, et al. Among authors: sedlakova i. Cesk Patol. 2005 Apr;41(2):51-9. Cesk Patol. 2005. PMID: 15966333 Czech.
[Chemoresistance/Chemosensitivity of ovarian cancer--a case report].
Sedláková I, Tosner J, Rezác A, Cervinka M, Tomsová M, Spacek J. Sedláková I, et al. Ceska Gynekol. 2008 Jun;73(3):140-3. Ceska Gynekol. 2008. PMID: 18646664 Czech.
[Prognostic significance of Pgp, MRP1, and MRP3 in ovarian cancer patients].
Sedláková I, Laco J, Tošner J, Špaček J. Sedláková I, et al. Ceska Gynekol. 2015 Dec;80(6):405-13. Ceska Gynekol. 2015. PMID: 26741154 Czech.
25 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback